**Exhibit
      99.1**


**CERTIFICATION**


**PURSUANT
      TO SECTION 302 OF**


**THE
      SARBANES-OXLEY ACT OF 2002**





I,
      Frederic P Zotos, certify that:





1.  I
      have reviewed this quarterly report on Form 10-QSB of Pathogenics,
      Inc.





2.  Based
      on my knowledge, this report does not contain any untrue statement of material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;





3.  Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the financial
      condition, results of operations and cash flows of the registrant as of, and
      for, the periods presented in this report;





4.  I
      am responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
      registrant and have:


a)
            designed
                such disclosure controls and procedures to ensure that material
                information relating to the registrant, including its consolidated
                subsidiaries, is made known to us by others within those entities,
                particularly during the period in which this report is being
                prepared;


b)
            evaluated
                the effectiveness of the registrant's disclosure controls and procedures
                as of a date within 90 days prior to the filing date of this report
                (the
                "Evaluation Date"); and


c)
            presented
                in this report our conclusions about the effectiveness of the disclosure
                controls and procedures based on our evaluation as of the Evaluation
                Date;





5.  I
      have disclosed, based on our most recent evaluation, to the registrant's
      auditors and the audit committee of the registrant's board of directors (or
      persons performing the equivalent function):


a)
            all
                significant deficiencies in the design or operation of internal controls
                which could adversely affect the registrant's ability to record,
                process,
                summarize and report financial data and have identified for the
                registrant's auditors any material weaknesses in internal controls;
                and


b)
            any
                fraud, whether or not material, that involves management or other
                employees who have a significant role in the registrant's internal
                controls; and





6.  I
      have indicated in this report whether or not there were significant changes
      in
      internal controls or in other factors that could significantly affect internal
      controls subsequent to the date of our most recent evaluation, including any
      corrective actions with regard to significant deficiencies and material
      weaknesses.





/s/
      Frederic P. Zotos


Frederic
      P. Zotos


President,
      Chief Executive Officer,


Director
      and Principal Financial and Accounting Officer








Date:  November
      14, 2007




10